Ads Enzymes Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 114.41%
(FY 2022)
- Profit 72.77%
(FY 2022)
- Ebitda -96.82%
(FY 2022)
- Net Worth -34.67%
(FY 2022)
- Total Assets 81.60%
(FY 2022)
About Ads Enzymes
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Sharma and Sunil Sharma serve as directors at the Company.
- CIN/LLPIN
U52609DL2017PTC319685
- Company No.
319685
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ads Enzymes Private Limited offer?
Ads Enzymes Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Ads Enzymes?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sharma  | Director | 23-Jun-2017 | Current |
| Sunil Sharma | Director | 23-Jun-2017 | Current |
Financial Performance of Ads Enzymes.
Ads Enzymes Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 114.41% increase. The company also saw a substantial improvement in profitability, with a 72.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ads Enzymes?
Unlock access to Ads Enzymes's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
E-Green Developers & Promoters Private LimitedActive 10 years 4 monthsAnil Sharma and Sunil Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ads Enzymes?
Unlock and access historical data on people associated with Ads Enzymes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ads Enzymes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ads Enzymes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.